Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.
Dynacure has raised €50M across 1 funding round from 1 investor, most recently a Series C round in Feb 2020. Based in Illkirch, France; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-04 | Series C |
| €50M |
| Perceptive Advisors |
| View deal → |
